Umeå University's logo

umu.sePublications
System disruptions
There are recurring service disruptions on some of the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Five-year results of nordic T1G2-3, a randomized trial comparing bcg with epirubicin and interferon alpha 2b
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2013 (English)In: Scandinavian journal of urology, ISSN 2168-1805, Vol. 47, no Suppl. 219, p. 19-20Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2013. Vol. 47, no Suppl. 219, p. 19-20
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:umu:diva-81021ISI: 000323611300021OAI: oai:DiVA.org:umu-81021DiVA, id: diva2:652339
Available from: 2013-09-30 Created: 2013-09-30 Last updated: 2025-02-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Johansson, Robert

Search in DiVA

By author/editor
Johansson, Robert
By organisation
Oncology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 551 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf